Hematology Medical Education
  • Forum
  • Webinars
    • upcoming
    • previous
  • Congresses
    • EHA 2022 Insider
  • Series
    • Myeloma Connect
    • Challenges in CLL
    • Challenges in NHL
  • Podcasts
    • Challenges in CLL
    • Challenges in NHL - mantle cell lymphoma
    • Challenges in NHL - Waldenström’s macroglobulinemia
  • Faculty
    • Scientific Committee
    • Christian Buske
    • Michel Delforge
    • Paolo Ghia
    • Faculty
    • Othman Al-Sawaf
    • Francesc Bosch
    • Lars Bullinger
    • Christian Buske
    • José Carda
    • Ajai Chari
    • Solène Clavreul
    • Ruth Clifford
    • Gordon Cook
    • Charles Craddock
    • Florence Cymbalista
    • Faith Davies
    • Michel Delforge
    • Niels van de Donk
    • Peter Dreger
    • Hermann Einsele
    • Toby Eyre
    • Carlos Fernández de Larrea
    • George Follows
    • Marianna Fontana
    • Gianluca Gaidano
    • Jaime Gállego Pérez-Larraya
    • Ramon Garcia-Sanz
    • Francesca Gay
    • Paolo Ghia
    • Irene Ghobrial
    • Maria Gomes da Silva
    • John Gribben
    • Georg Hess
    • Graham Jackson
    • Efstathios Kastritis
    • Arnon Kater
    • Steven Le Gouill
    • Véronique Leblond
    • Xavier Leleu
    • Yi Lin
    • Teresa López-Fernández
    • Stefano Luminari
    • Thomas Lund
    • Salomon Manier
    • Ana Marín Niebla
    • Joaquin Martinez-Lopez
    • María Victoria Mateos
    • Paolo Milani
    • Roberto Mina
    • Monique Minnema
    • Mohamad Mohty
    • Pau Montesinos
    • Philippe Moreau
    • Carol Moreno
    • Talha Munir
    • Inger Nijhof
    • Mario Nuvolone
    • Roger Owen
    • Bruno Paiva
    • Giovanni Palladini
    • Raffaele Palmieri
    • Charlotte Pawlyn
    • Rakesh Popat
    • Christiane Pott
    • Noemi Puig
    • Karthik Ramasamy
    • Andrew Rawstron
    • Paula Rodriguez Otero
    • Richard Rosenquist
    • Davide Rossi
    • Jesús San Miguel
    • Lydia Scarfò
    • Fredrik Schjesvold
    • Emma Searle
    • Paolo Sportoletti
    • Kostas Stamatopoulos
    • Stephan Stilgenbauer
    • Catherine Thieblemont
    • Max Topp
    • Steve Treon
    • Saad Zafar Usmani
    • Adriano Venditti
    • Ashutosh Wechalekar
    • Katja Weisel
    • Agnieszka Wierzbowska
    • Kwee Yong
    • Elena Zamagni
    • Sonja Zweegman
Log in
  • All
  • CLL
  • NHL
  • Amyloidosis
  • NDMM
  • RRMM
  • Other
ASH 2022: Updates in AML Discussed
24 January 2023 - 1 Hours

ASH 2022: Updates in AML Discussed

AML

more info...

Faculty

Charles Craddock

Charles Craddock

Raffaele Palmieri

Raffaele Palmieri

Pau Montesinos

Pau Montesinos
Play now
EM-115126
The role of the multidisciplinary team in the management of patients with AL amyloidosis
1 December 2022 - 47 Minutes

The role of the multidisciplinary team in the management of patients with AL amyloidosis

Amyloidosis~Multiple Myeloma~myelomaconnect

more info...

Faculty

Mohamad Mohty

Mohamad Mohty

Marianna Fontana

Marianna Fontana

Monique Minnema

Monique Minnema
Play now
EM-93566
Challenges in CLL: how could the data from ASH 2022 impact your clinical practice?
30 November 2022 - 59 Minutes

Challenges in CLL: how could the data from ASH 2022 impact your clinical practice?

challengesincll~CLL

more info...

Faculty

John Gribben

John Gribben

Paolo Ghia

Paolo Ghia

Othman Al-Sawaf

Othman Al-Sawaf
Play now
EM-92737
Challenges in NHL: Optimising first-line treatment in MCL
17 November 2022 - 47 Minutes

Challenges in NHL: Optimising first-line treatment in MCL

challengesinnhl~NHL

more info...

Faculty

Georg Hess

Georg Hess

Christian Buske

Christian Buske

Ana Marín Niebla

Ana Marín Niebla

Toby Eyre

Toby Eyre

Stefano Luminari

Stefano Luminari
Play now
EM-92751
What are the key drivers for selecting ideal RRMM patients for treatment with CAR T-cell therapy?
16 November 2022 - 46 Minutes

What are the key drivers for selecting ideal RRMM patients for treatment with CAR T-cell therapy?

Multiple Myeloma~myelomaconnect~RRMM

more info...

Faculty

Michel Delforge

Michel Delforge

Joaquin Martinez-Lopez

Joaquin Martinez-Lopez

Hermann Einsele

Hermann Einsele
Play now
EM-93624
A focus on standard risk patients with MM and the roadmap to cure
15 November 2022 - 44 Minutes

A focus on standard risk patients with MM and the roadmap to cure

Multiple Myeloma~myelomaconnect~NDMM

more info...

Faculty

Mohamad Mohty

Mohamad Mohty

Jesús San Miguel

Jesús San Miguel
Play now
EM-93617
INSIDER: Highlights from the 11th International Workshop on Waldenström’s Macroglobulinemia
9 November 2022 - 50 Minutes

INSIDER: Highlights from the 11th International Workshop on Waldenström’s Macroglobulinemia

challengesinnhl~NHL

more info...

Faculty

Christian Buske

Christian Buske

Ramon Garcia-Sanz

Ramon Garcia-Sanz

Steve Treon

Steve Treon
Play now
EM-96531
Challenges in CLL: Continuous, time-limited, or MRD-guided therapy
8 November 2022 - 46 Minutes

Challenges in CLL: Continuous, time-limited, or MRD-guided therapy

challengesincll~CLL

more info...

Faculty

Paolo Ghia

Paolo Ghia

Talha Munir

Talha Munir

José Carda

José Carda
Play now
EM-92734
What are the key drivers for selecting ideal RRMM patients for treatment with bispecific antibodies?
25 October 2022 - 49 Minutes

What are the key drivers for selecting ideal RRMM patients for treatment with bispecific antibodies?

Multiple Myeloma~myelomaconnect~RRMM

more info...

Faculty

Michel Delforge

Michel Delforge

Paula Rodriguez Otero

Paula Rodriguez Otero

Philippe Moreau

Philippe Moreau
Play now
EM-93607
How do we ensure we choose the right treatment for the right patient?
4 October 2022 - 46 Minutes

How do we ensure we choose the right treatment for the right patient?

Multiple Myeloma~myelomaconnect~NDMM

more info...

Faculty

Mohamad Mohty

Mohamad Mohty

Faith Davies

Faith Davies

Charlotte Pawlyn

Charlotte Pawlyn
Play now
EM-93604
  • 1
  • 2
  • 3
hme webinar
  • Webinars
  • Faculty
  • Scientific Committee
  • Register
  • About HME
  • Support
  • Legal Disclaimer

© Janssen Pharmaceutica NV 2016 Turnhoutseweg 30, B-2340 Beerse — Belgium - All rights reserved

The views expressed within are those of the individual faculty members and do not necessarily reflect the view of Janssen, Pharmaceutical Companies of Johnson and Johnson.

The program and the content of the presentations is owned by the Scientific Third Party Committee and the respective faculty members and may include discussions on off label data of products and therapies.

This site is managed in accordance with Belgian Law, and is published by Janssen Pharmaceutica NV, who is solely responsible for its management. The site is intended for healthcare professionals from Europe, Middle East and Africa. Your use of this site implies your tacit agreement with the application of Belgian and European legislation and with our Privacy Policy.

Privacy Policy - Cookie Policy

CP-338116 - Date of preparation: September 2022